论文部分内容阅读
近年来新生儿惊厥的治疗研究进展很快,尤其是苯巴比妥负荷量疗法的研究和应用,在很多新生儿惊厥性疾病取得了较好疗效。我科于1992年以来应用苯巴比妥负荷量疗法治疗新生儿颅内出血(ICH)42例,现将结果报告分析如下。1 资料与方法1.1 一般资料:1992年以来我科收治的ICH患儿66例随机分为治疗组和对照组,治疗组42例采用苯巴比妥负荷量疗法,对照组24例采用苯巴比妥传统给药方法。治疗组42例中男27例,女14例,其中早产儿13例,合并肺炎9例,硬肿症18例,肺出血4例,败血症2例,高胆红素血症13例;对照组24例中男18例,女6例,其中早产儿4例,合并肺炎5例,硬肿症8例,肺出血3例,高胆红素血症6例。
In recent years, the treatment of neonatal convulsions progress rapidly, especially the phenobarbital load therapy research and application, in many neonatal convulsive disease has achieved good results. Our department since 1992, the application of phenobarbital load therapy for neonatal intracranial hemorrhage (ICH) in 42 cases, the results report is now analyzed as follows. 1 Materials and Methods 1.1 General Information: Since 1992, ICH children admitted to our department 66 cases were randomly divided into treatment group and control group, the treatment group 42 cases with phenobarbital load therapy, 24 cases in the control group with phenobarbital The traditional method of administration. In the treatment group, there were 42 males and 27 females with 14 females, including 13 preterm infants, 9 pneumonia, 18 scleredema, 4 pulmonary hemorrhage, 2 sepsis and 13 hyperbilirubinemia. The control group There were 18 males and 6 females in 24 cases, including 4 premature infants, 5 pneumonia, 8 sclerodema, 3 pulmonary hemorrhage and 6 hyperbilirubinemia.